Vesalio announces it has accomplished a key FDA IDE study milestone to support entry into the US neurovascular market. Enrollment in the VITAL(1) clinical trial, assessing the company’s NeVa VS™ technology in the treatment of symptomatic cerebral vasospasm following aneurysmal subarachnoid…
Source
Hand crafted Music Video Reviews you can share and discuss fast at scale.
Powered by:
Powered by 
Features
- Music Articles (soon)
Our Network
- (soon)